Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{182902,
        author = {Suman Mondal},
        title = {Emerging CRISPR-Cas Platforms for Rapid and Field-Deployable Detection of Multidrug-Resistant Microbes},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {2},
        pages = {3517-3527},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=182902},
        abstract = {The emergence and global spread of multidrug-resistant (MDR) microbes present a critical challenge to infectious disease management, necessitating rapid, accurate, and decentralized diagnostic solutions. Traditional microbiological methods remain constrained by prolonged turnaround times, infrastructure dependence, and suboptimal sensitivity. CRISPR-Cas systems, originally discovered as bacterial immune mechanisms, have since been repurposed into next-generation diagnostic platforms with remarkable specificity and versatility. This review explores the diagnostic capabilities of emerging CRISPR-based technologies such as SHERLOCK, DETECTR, and Cas12/13/14 systems, with a focus on their application in MDR pathogen detection. Particular attention is given to the ability of these platforms to target resistance genes in clinical and environmental samples, often without nucleic acid amplification. The integration of CRISPR diagnostics with isothermal amplification, microfluidic chips, and smartphone-compatible formats is also examined for field-deployable use. Current challenges including off-target effects, assay standardization, and regulatory hurdles are discussed alongside prospective solutions for broad clinical implementation against the rising AMR threat.},
        keywords = {CRISPR-Cas systems, multidrug-resistant microbes, antimicrobial resistance, molecular diagnostics.},
        month = {July},
        }